![]() |
![]() |
My Amedeo
![]() ![]() ![]() |
![]() |
|||||||||
Stroke prevention |
Influenza |
Free Subscription
1 Arch Virol |
Retrieve available abstracts of this week’s articles:
HTML format |
Single Articles |
AMEDEO Influenza is free of charge.
Mpox: a review of laboratory detection techniques.
Arch Virol. 2023;168:221.
PubMed
Abstract available
Covid-19: Hospital admissions rise in England amid fears of new variant and
waning immunity.
BMJ. 2023;382:p1833.
PubMed
Covid-19: Payment to general practices to deliver vaccines to be cut by 25.
BMJ. 2023;382:1821.
PubMed
Covid-19: Latin America defies nationalism and circumstance to develop its own
vaccines.
BMJ. 2023;382:1351.
PubMed
Covid-19: US agency launches raft of clinical trials of treatments for long
covid.
BMJ. 2023;382:p1797.
PubMed
Unveiling TMEM106B: SARS-CoV-2's secret entrance to the cell.
Cell. 2023;186:3329-3331.
PubMed
Abstract available
TMEM106B is a receptor mediating ACE2-independent SARS-CoV-2 cell entry.
Cell. 2023;186:3427-3442.
PubMed
Abstract available
Genomic epidemiology of SARS-CoV-2 in large university hospital cohort: the
UnCoVER-Brazil project.
Epidemiol Infect. 2023;151:e126.
PubMed
Abstract available
Identification of post-COVID-19 condition phenotypes, and differences in
health-related quality of life and healthcare use: a cluster analysis.
Epidemiol Infect. 2023;151:e123.
PubMed
Abstract available
Incidence of SARS-CoV-2 infection and associated risk factors among staff and
residents at homeless shelters in King County, Washington: an active surveillance
study.
Epidemiol Infect. 2023;151:e129.
PubMed
Abstract available
Development and external validation of a prognostic tool for nonsevere COVID-19
inpatients.
Epidemiol Infect. 2023;151:e128.
PubMed
Abstract available
The RNA-Splicing Ligase RTCB Promotes Influenza A Virus Replication by
Suppressing Innate Immunity via Interaction with RNA Helicase DDX1.
J Immunol. 2023 Aug 9:ji2200799. doi: 10.4049/jimmunol.2200799.
PubMed
Abstract available
The Emerging Role of MAIT Cell Responses in Viral Infections.
J Immunol. 2023;211:511-517.
PubMed
Abstract available
Neutralizing antibodies response to novel SARS-CoV-2 omicron sublineages in
long-term care facility residents after the fourth dose of monovalent BNT162b2
COVID-19 vaccination.
J Infect. 2023 Jun 30:S0163-4453(23)00342-0. doi: 10.1016/j.jinf.2023.
PubMed
Nucleocapsid-Specific Antibodies as a Correlate of Protection against SARS-CoV-2
Reinfection in Children.
J Infect. 2023 Jun 28:S0163-4453(23)00340-7. doi: 10.1016/j.jinf.2023.
PubMed
Genomic characteristics of SARS-CoV-2 variants and their clinical impact on
patients with COVID-19 in Taiwan.
J Infect. 2023 Jun 27:S0163-4453(23)00341-9. doi: 10.1016/j.jinf.2023.
PubMed
Reactogenicity, immunogenicity and breakthrough infections following heterologous
or fractional second dose COVID-19 vaccination in adolescents (Com-COV3): A
Randomised Controlled Trial.
J Infect. 2023 Jun 16:S0163-4453(23)00330-4. doi: 10.1016/j.jinf.2023.
PubMed
Abstract available
AUTHORS' REPLY TO A COMMENTARY ON THE POTENTIAL IMPACT OF COVID-19 PASSPORTS TO
EPIDEMIOLOGICAL SITUATION.
J Infect. 2023 Jun 15:S0163-4453(23)00333-X. doi: 10.1016/j.jinf.2023.
PubMed
Safety and Immunogenicity against Ancestral, Delta and Omicron Virus Variants
Following a Booster Dose of an Inactivated Whole-Virus COVID-19 Vaccine
(VLA2001): Interim analysis of an open-label extension of the randomized,
controlled, phase 3 COV-COM
J Infect. 2023 Jul 3:S0163-4453(23)00367-5. doi: 10.1016/j.jinf.2023.
PubMed
Abstract available
Evaluation of the neutralizing antibody response against the omicron variant
produced by heterologous or hybrid immunity: How does the fifth dose of COVID-19
vaccine affect the neutralizing antibody response?
J Infect. 2023 Jul 4:S0163-4453(23)00369-9. doi: 10.1016/j.jinf.2023.
PubMed
Influence of a chronic Schistosoma mansoni infection on the outcomes of a
SARS-CoV-2 infection in the hamster model.
J Infect. 2023 Jul 5:S0163-4453(23)00374-2. doi: 10.1016/j.jinf.2023.
PubMed
Long COVID: Potential role of the Reactive Species Interactome.
J Infect. 2023 Jul 11:S0163-4453(23)00376-6. doi: 10.1016/j.jinf.2023.
PubMed
Outcomes of hematologic malignancy patients with SARS-CoV-2 breakthrough
infections after tixagevimab-cilgavimab during community transmission of
monoclonal antibody resistant variants.
J Infect. 2023 Jul 13:S0163-4453(23)00378-X. doi: 10.1016/j.jinf.2023.
PubMed
COVID-19 Vaccination Among Patients Receiving Maintenance Renal Replacement
Therapy: Immune Response, Real-World Effectiveness, and Implications for the
Future.
J Infect Dis. 2023;228.
PubMed
Abstract available
Susceptibility to SARS-CoV-2 Infection and Immune Responses to COVID-19
Vaccination Among Recipients of Solid Organ Transplants.
J Infect Dis. 2023;228.
PubMed
Abstract available
Foreword: Preventing COVID-19 Among the Immunocompromised Population.
J Infect Dis. 2023;228.
PubMed
Abstract available
SARS-CoV-2 Infection and Response to COVID-19 Vaccination in Patients With
Primary Immunodeficiencies.
J Infect Dis. 2023;228.
PubMed
Abstract available
A Call to Action: Current Challenges and Considerations for COVID-19 Vaccination
in Immunocompromised Populations.
J Infect Dis. 2023;228.
PubMed
Abstract available
The Burden of COVID-19 in the Immunocompromised Patient: Implications for
Vaccination and Needs for the Future.
J Infect Dis. 2023;228.
PubMed
Abstract available
COVID-19 Vaccination in Patients With Cancer and Patients Receiving HSCT or CAR-T
Therapy: Immune Response, Real-World Effectiveness, and Implications for the
Future.
J Infect Dis. 2023;228.
PubMed
Abstract available
Susceptibility to COVID-19 and Immunologic Response to Vaccination in Patients
With Immune-Mediated Inflammatory Diseases.
J Infect Dis. 2023;228.
PubMed
Abstract available
Changes in the epidemiology of pediatric sinogenic and otogenic intracranial
infections during the COVID-19 pandemic: a single-institution study.
J Neurosurg Pediatr. 2023;32:231-241.
PubMed
Abstract available
The M2 proteins of bat influenza A viruses reveal atypical features compared to
conventional M2 proteins.
J Virol. 2023 Aug 4:e0038823. doi: 10.1128/jvi.00388.
PubMed
Abstract available
Promoting Data Harmonization of COVID-19 Research in Pregnant and Pediatric
Populations.
JAMA. 2023 Jul 20. doi: 10.1001/jama.2023.10835.
PubMed
Monoclonal Antibody and Oral Antiviral Treatment of SARS-CoV-2 Infection in US
Nursing Homes.
JAMA. 2023 Jul 14:e2312945. doi: 10.1001/jama.2023.12945.
PubMed
Learning from serosurveillance for SARS-CoV-2 to inform pandemic preparedness and
response.
Lancet. 2023 May 26:S0140-6736(23)00964-9. doi: 10.1016/S0140-6736(23)00964.
PubMed
Notes from the Field: Safety Monitoring of Novavax COVID-19 Vaccine Among Persons
Aged >/=12 Years - United States, July 13, 2022-March 13, 2023.
MMWR Morb Mortal Wkly Rep. 2023;72:850-851.
PubMed
Evolutionary safety of lethal mutagenesis driven by antiviral treatment.
PLoS Biol. 2023;21:e3002214.
PubMed
Abstract available
Incidence of diabetes following COVID-19 vaccination and SARS-CoV-2 infection in
Hong Kong: A population-based cohort study.
PLoS Med. 2023;20:e1004274.
PubMed
Abstract available
Dynamic spillovers and portfolio implication between green cryptocurrencies and
fossil fuels.
PLoS One. 2023;18:e0288377.
PubMed
Abstract available
Identification of novel lactic acid bacteria with enhanced protective effects
against influenza virus.
PLoS One. 2023;18:e0273604.
PubMed
Abstract available
N-dihydrogalactochitosan reduces mortality in a lethal mouse model of SARS-CoV-2.
PLoS One. 2023;18:e0289139.
PubMed
Abstract available
Exploring Hikikomori-like idiom of distress a year into the SARS-CoV-2 pandemic
in Oman: Factorial validity of the 25-item Hikikomori Questionnaire, prevalence
and associated factors.
PLoS One. 2023;18:e0279612.
PubMed
Abstract available
COVID-19 resilience index in European Union countries based on their risk and
readiness scale.
PLoS One. 2023;18:e0289615.
PubMed
Abstract available
Enterprise resilience to the COVID-19 pandemic: The role of business environment.
PLoS One. 2023;18:e0288722.
PubMed
Abstract available
Analysis of altered level of blood-based biomarkers in prognosis of COVID-19
patients.
PLoS One. 2023;18:e0287117.
PubMed
Abstract available
Methods for improving participation rates in national self-administered web/mail
surveys: Evidence from the United States.
PLoS One. 2023;18:e0289695.
PubMed
Abstract available
Impact of vaccination and risk factors on COVID-19 mortality amid delta wave in
Libya: A single center cohort study.
PLoS One. 2023;18:e0289490.
PubMed
Abstract available
The association between COVID-19 preventive behaviors and mental health
conditions.
PLoS One. 2023;18:e0289533.
PubMed
Abstract available
The prevalence of pediatric asthma hospitalizations at different stages of the
COVID-19 pandemic: A systematic review and meta-analysis study protocol.
PLoS One. 2023;18:e0289538.
PubMed
Abstract available
Vascular mechanisms leading to progression of mild cognitive impairment to
dementia after COVID-19: Protocol and methodology of a prospective longitudinal
observational study.
PLoS One. 2023;18:e0289508.
PubMed
Abstract available
From colorblind to systemic racism: Emergence of a rhetorical shift in higher
education discourse in response to the murder of George Floyd.
PLoS One. 2023;18:e0289545.
PubMed
Abstract available
Pregnant women with mild COVID-19 followed in community setting by telemedicine,
and factors associated with unfavorable outcome.
PLoS One. 2023;18:e0288845.
PubMed
Abstract available
Better data for decision-making through Bayesian imputation of suppressed
provisional COVID-19 death counts.
PLoS One. 2023;18:e0288961.
PubMed
Abstract available
Impact of vaccination on infection or death from COVID-19 in individuals with
laboratory-confirmed cases: Case-control study.
PLoS One. 2023;18:e0265698.
PubMed
Abstract available
Substance use, psychiatric symptoms, personal mastery, and social support among
COVID-19 long haulers: A compensatory model.
PLoS One. 2023;18:e0289413.
PubMed
Abstract available
Knowledge, attitudes and practices towards COVID-19: Community survey in southern
Ethiopia.
PLoS One. 2023;18:e0288430.
PubMed
Abstract available
Understanding the efficacy of wastewater surveillance for SARS-CoV-2 in two
diverse communities.
PLoS One. 2023;18:e0289343.
PubMed
Abstract available
Plant medicine usage of people living with type 2 diabetes mellitus in Belize: A
qualitative exploratory study.
PLoS One. 2023;18:e0289212.
PubMed
Abstract available
Point-of-care PCR testing of SARS-CoV-2 in the emergency department: Influence on
workflow and efficiency.
PLoS One. 2023;18:e0288906.
PubMed
Abstract available
Community coalitions for smoke-free environments in Armenia and Georgia: A mixed
methods analysis of coalition formation, implementation and perceived
effectiveness.
PLoS One. 2023;18:e0289149.
PubMed
Abstract available
Impacts of environmental uncertainty on investment stocks perception under the
holiday effect.
PLoS One. 2023;18:e0284745.
PubMed
Abstract available
An iron-sulfur cluster in the zinc-binding domain of the SARS-CoV-2 helicase
modulates its RNA-binding and -unwinding activities.
Proc Natl Acad Sci U S A. 2023;120:e2303860120.
PubMed
Abstract available
The genomic landscape of swine influenza A viruses in Southeast Asia.
Proc Natl Acad Sci U S A. 2023;120:e2301926120.
PubMed
Abstract available
Association of vaccination, international travel, public health and social
measures with lineage dynamics of SARS-CoV-2.
Proc Natl Acad Sci U S A. 2023;120:e2305403120.
PubMed
Abstract available
Reconstructing household transmission dynamics to estimate the infectiousness of
asymptomatic influenza virus infections.
Proc Natl Acad Sci U S A. 2023;120:e2304750120.
PubMed
Abstract available
COVID-19 booster vaccination during pregnancy enhances maternal binding and
neutralizing antibody responses and transplacental antibody transfer to the
newborn.
Vaccine. 2023 Jun 13:S0264-410X(23)00698-9. doi: 10.1016/j.vaccine.2023.
PubMed
Abstract available
COVID-19 mRNA vaccines as hypothetical epigenetic players: Results from an in
silico analysis, considerations and perspectives.
Vaccine. 2023 Jul 13:S0264-410X(23)00819-8. doi: 10.1016/j.vaccine.2023.
PubMed
Abstract available
Let's talk about COVID-19 vaccination: Relevance of conversations about COVID-19
vaccination and information sources on vaccination intention in Switzerland.
Vaccine. 2023 Jul 5:S0264-410X(23)00807-1. doi: 10.1016/j.vaccine.2023.
PubMed
Abstract available
Safety and adverse effects of the coronavirus disease 2019 vaccine among the
general Japanese adult population.
Vaccine. 2023 Apr 26:S0264-410X(23)00469-3. doi: 10.1016/j.vaccine.2023.
PubMed
Abstract available
Social inequalities and the early provision and dispersal of COVID-19
vaccinations in the United States: A population trends study.
Vaccine. 2023 Jul 15:S0264-410X(23)00833-2. doi: 10.1016/j.vaccine.2023.
PubMed
Abstract available
Immunogenicity and safety in pigs of PHH-1V, a SARS-CoV-2 RBD fusion heterodimer
vaccine candidate.
Vaccine. 2023 Jul 15:S0264-410X(23)00820-4. doi: 10.1016/j.vaccine.2023.
PubMed
Abstract available
Barriers to COVID-19 vaccination of migrant populations: A qualitative interview
study of immunisation providers in Victoria, Australia.
Vaccine. 2023 Jul 3:S0264-410X(23)00804-6. doi: 10.1016/j.vaccine.2023.
PubMed
Abstract available
Vaccine hesitancy comes in waves: Longitudinal evidence on willingness to
vaccinate against COVID-19 from seven European countries.
Vaccine. 2023 Jul 15:S0264-410X(23)00829-0. doi: 10.1016/j.vaccine.2023.
PubMed
Abstract available
Determining the true incidence of seasonal respiratory syncytial virus-confirmed
hospitalizations in preterm and term infants in Western Australia.
Vaccine. 2023;41:5216-5220.
PubMed
Abstract available
Safety signal identification for COVID-19 bivalent booster vaccination using
tree-based scan statistics in the Vaccine Safety Datalink.
Vaccine. 2023 Jul 19:S0264-410X(23)00823-X. doi: 10.1016/j.vaccine.2023.
PubMed
Abstract available
Re-evaluation of the risk of venous thromboembolism after COVID-19 vaccination
using haematological criteria.
Vaccine. 2023 Jun 7:S0264-410X(23)00662-X. doi: 10.1016/j.vaccine.2023.
PubMed
Abstract available
Safety profile and SARS-CoV-2 breakthrough infections among HCWs receiving
anti-SARS-CoV-2 and influenza vaccines simultaneously: an Italian observational
study.
Vaccine. 2023 Aug 4:S0264-410X(23)00874-5. doi: 10.1016/j.vaccine.2023.
PubMed
Abstract available
Contributions of cost-effectiveness analyses (CEA) to influenza vaccination
policy for older adults in Europe.
Vaccine. 2023 Aug 5:S0264-410X(23)00919-2. doi: 10.1016/j.vaccine.2023.
PubMed
Abstract available
Heavy bleeding and other menstrual disturbances in young women after COVID-19
vaccination.
Vaccine. 2023 Jul 3:S0264-410X(23)00801-0. doi: 10.1016/j.vaccine.2023.
PubMed
Abstract available
Immunogenicity and protective effects of recombinant bivalent COVID-19 vaccine in
mice and rhesus macaques.
Vaccine. 2023 Jun 30:S0264-410X(23)00789-2. doi: 10.1016/j.vaccine.2023.
PubMed
Abstract available
Impact of COVID vaccine and comorbidities in patients receiving
casirivimab-imdevimab monoclonal antibody during SARS-CoV-2 B.1.617.2 (Delta)
surge: A real-world study.
Vaccine. 2023 Jul 12:S0264-410X(23)00822-8. doi: 10.1016/j.vaccine.2023.
PubMed
Abstract available
Exclusion of pregnant people from emergency vaccine clinical trials: A systematic
review of clinical trial protocols and reporting from 2009 to 2019.
Vaccine. 2023 Jul 11:S0264-410X(23)00776-4. doi: 10.1016/j.vaccine.2023.
PubMed
Abstract available
Social processes, practical issues, and COVID-19 vaccination among hesitant
adults.
Vaccine. 2023 Jul 7:S0264-410X(23)00809-5. doi: 10.1016/j.vaccine.2023.
PubMed
Abstract available
Safety surveillance of the NVX-CoV2373 COVID-19 vaccine among Koreans aged
18 years and over.
Vaccine. 2023 Jun 27:S0264-410X(23)00780-6. doi: 10.1016/j.vaccine.2023.
PubMed
Abstract available
Burden of illness associated with Respiratory Syncytial Virus (RSV)-related
hospitalizations among adults in Ontario, Canada: A retrospective
population-based study.
Vaccine. 2023;41:5141-5149.
PubMed
Abstract available
Vaccination, human mobility, and COVID-19 health outcomes: Empirical comparison
before and during the outbreak of SARS-Cov-2 B.1.1.529 (Omicron) variant.
Vaccine. 2023 May 29:S0264-410X(23)00617-5. doi: 10.1016/j.vaccine.2023.
PubMed
Abstract available
Prevalence and characterization of seven-segmented influenza viruses in bovine
respiratory disease complex.
Virology. 2023;587:109859.
PubMed
Abstract available
Antiviral activity of singlet oxygen-photogenerating perylene compounds against
SARS-CoV-2: Interaction with the viral envelope and photodynamic virion
inactivation.
Virus Res. 2023;334:199158.
PubMed
Abstract available
Incidence of Epstein-Barr virus reactivation is elevated in COVID-19 patients.
Virus Res. 2023;334:199157.
PubMed
Abstract available
Anthracyclines inhibit SARS-CoV-2 infection.
Virus Res. 2023;334:199164.
PubMed
Abstract available
First sequenced cases of Omicron BA.2 sublineage in Ecuador.
Virus Res. 2023;334:199169.
PubMed
Abstract available
SARS-CoV-2 inhibitory activity of a short peptide derived from internal fusion
peptide of S2 subunit of spike glycoprotein.
Virus Res. 2023;334:199170.
PubMed
Abstract available
Construction of Fosmid-based SARS-CoV-2 replicons for antiviral drug screening
and replication analyses in biosafety level 2 facilities.
Virus Res. 2023;334:199176.
PubMed
Abstract available
Establishing immunogenicity and safety of needle-free intradermal delivery by
nanoporous ceramic skin patch of mRNA SARS-CoV-2 vaccine as a revaccination
strategy in healthy volunteers.
Virus Res. 2023 Jul 18:199175. doi: 10.1016/j.virusres.2023.199175.
PubMed
Abstract available
MERS-CoV RBD-mRNA vaccine induces potent and broadly neutralizing antibodies with
protection against MERS-CoV infection.
Virus Res. 2023;334:199156.
PubMed
Abstract available
Thank you for your interest in scientific medicine.
This policy is made possible thanks to
a media sponsorship by